Business

Mass. Movers

The numbers are looking good for NxStage

A NxStage home hemodialysis machine.

Globe file photo

A NxStage home hemodialysis machine.

Lawrence’s NxStage Medical Inc. jumped after the dialysis products manufacturer’s preliminary fourth-quarter sales numbers beat its own and analysts’ expectations. NxStage said it expects revenue of about $69 million, above its earlier guidance of between $67 and $68.5 million. The Street estimated $67.8 million. “ . . . we continue to target 15 percent annual revenue growth in the home in 2014,” CEO Jeffrey Burbank said in a statement. For the full year 2013, NxStage expects revenue of $263 million, above estimates.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com